Chinese pharmaceutical firms are plunging as a drug safety scandal spills over to become a sector-wide trust crisis.

Authorities found Changsheng Biotechnology’s subsidiary produced substandard vaccines and forged production data. Its shares have been suspended from trading.

Related Posts:

We truly are under attack. We need user support now more than ever! For as little as $10, you can support the IWB directly – and it only takes a minute. Thank you. 541 views